Alcon Inc.

ALC

CH0432492467

Medical Equipment, Supplies & Distribution

Market Closed - Swiss Exchange Other stock markets 11:31:30 2024-04-26 am EDT			5-day change	1st Jan Change
72 ^CHF	+0.61%		-0.66%	+9.69%

Mar. 26	Alcon Announces Management Changes	CI
Mar. 26	Alcon’s Medical Chief to Retire; Successor Named	MT

ALCON : JP Morgan remains Neutral

August 22, 2019 at 04:26 am EDT

Initially Neutral on the company, JP Morgan's analyst James Gordon maintained his recommendation.. The target price continues to be set at CHF 56.

Latest news about Alcon Inc.

Alcon Announces Management Changes	Mar. 26	CI
Alcon’s Medical Chief to Retire; Successor Named	Mar. 26	MT
Alcon Inc. Launches Clareon Presbyopia Correcting IOLs in India	Mar. 12	CI
UBS Boosts Alcon PT, Affirms Buy Rating	Mar. 08	MT
ALCON : price target raised by UBS	Mar. 08	CF
Argus Raises Alcon's Price Target to $100 From $90, Maintains Buy Rating	Mar. 04	MT
Mizuho Securities Raises Price Target on Alcon to $100 From $95, Maintains Buy Rating	Mar. 01	MT
Cooper Companies lifts annual revenue forecast on strong contact lens demand	Feb. 29	RE
Needham Raises Alcon's PT to $98 From $86 After 'Solid' Q4 2023 Results, Above-Consensus 2024 Guidance; Keeps Buy Rating	Feb. 28	MT
Swiss Market Index Extends Losses; Alcon Shines	Feb. 28	MT
Global markets live: Reckitt, Apple, Warner, Eli Llily, Intel...	Feb. 28
Transcript : Alcon Inc., Q4 2023 Earnings Call, Feb 28, 2024	Feb. 28
ALCON : Despite the slight Q4 miss, the markets cheered the 2024 guidance	Feb. 28
Alcon Posts Rise in FY23 Net Income, Revenue	Feb. 27	MT
Alcon Q4 Core Earnings, Sales Rise; 2024 Guidance Issued, 2023 Dividend Proposed	Feb. 27	MT
(ALC) ALCON Expects Fiscal Year 2024 EPS Range $3.00 - $3.10	Feb. 27	MT
Earnings Flash (ALC) ALCON Reports Q4 Revenue $2.35B	Feb. 27	MT
Alcon Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 27	CI
Earnings Flash (ALC) ALCON Posts Q4 EPS $0.70	Feb. 27	MT
Alcon Inc. Proposes Dividend for the Year 2023, Payable on or Around May 16, 2024	Feb. 27	CI
Alcon Inc. Provides Earnings Guidance for the Year 2024	Feb. 27	CI
Alcon Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 27	CI
KeyBanc Initiates Alcon at Overweight Rating With $87 Price Target	Feb. 06	MT
Bernstein Initiates Alcon at Outperform With $94.40 Price Target	Jan. 23	MT
Transcript : Alcon Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-10-2024 03:00 PM	Jan. 10

Alcon Inc. is the global leader in the design, manufacture and marketing of ophthalmic care products. Net sales break down by category of products as follows: - ophthalmic surgical products and equipment (56.7%): consumables (51.2% of net sales), implantable products (32%) and other products (16.8%; in particular surgical equipment) for the treatment of cataracts, retinal diseases, glaucoma and refractive errors; - vision care products (43.3%): contact lenses (59.2% of sales) and eye care products (40.8%; eye drops and ophthalmic ointments, etc.) At the end of 2023, the group operated 19 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (0.7%), the United States (46%), Japan (6.2%), China (5.6%) and other (41,5%).

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-07 - Annual General Meeting

Related indices

SMI , STOXX EUROPE 600 (EUR)

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

ALCON : Despite the slight Q4 miss, the markets cheered the 2024 guidance

February 28, 2024 at 07:44 am EST

ALCON : Optimum visibility for the future

May 29, 2023 at 06:08 am EDT

More Strategies

Ratings for Alcon Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

78.71 USD

Average target price

93.32 USD

Spread / Average Target

+18.56%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Glasses, Spectacles & Contact Lenses

	1st Jan change	Capi.
ALCON INC.	+9.69%	38.82B
ESSILORLUXOTTICA	+11.95%	98.12B
THE COOPER COMPANIES, INC.	-6.10%	17.66B
AUTEK CHINA INC.	-20.02%	2.24B
WARBY PARKER INC.	-8.37%	1.54B
PEGAVISION CORPORATION	+29.63%	1.23B
MENICON CO., LTD.	-35.36%	735M
MINGYUE OPTICAL LENS CO.,LTD.	-35.62%	747M
UNIVERSAL VISION BIOTECHNOLOGY CO., LTD.	-13.36%	623M
VIZIONFOCUS INC.	+24.04%	494M

Glasses, Spectacles & Contact Lenses

Alcon Inc.

Equities

ALC

CH0432492467

Medical Equipment, Supplies & Distribution

ALCON : JP Morgan remains Neutral

Latest news about Alcon Inc.

Chart Alcon Inc.

Company Profile

Income Statement Evolution

Analysis / Opinion

Ratings for Alcon Inc.

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Glasses, Spectacles & Contact Lenses